Dr. Nagesh Borse, Ph.D.

Dr. Nagesh N. Borse has 20+ years of experience leading global health strategy development, USG-funded programs, and developing and managing research activities. US government­-funded large projects in more than 20 countries in sub-Saharan Africa. Latin America, Eastern Europe, and Southeast Asia. During his time at CDC, USAID, Merck, USP, WHO/Geneva, and WHO WPRO, he has actively worked in childhood and adult vaccines, HIV/AIDS, COVID-19, H1N1, childhood injuries, breast cancer, pharmaceutical management, and oral health.

In his last position as Director at the United States Pharmacopeia (USP) Global Health Technical Program, Dr. Borse led global COVID-19 pandemic response and vaccine introduction activities in low- and middle-income countries; managed the USAID-funded Kyrgyzstan Cure TB project and provided strategic support to organizations such as the South African Health Products Authority (SAHPRA).

Before USP, Dr. Borse was the acting Director for the PEPFAR-funded USAID Global Health Supply Chain – Procurement and Supply Chain Management (GHSC-PSM) for HIV/AIDS task order. He led the development of data-driven, evidence-based oversight tools, and dashboards and managed the first-line ARV transition to new treatment options. PEPFAR then adapted his work in its country’s operation planning as best practices.

Dr. Borse worked with USAID/Namibia, where he played a critical role in introducing Pre-exposure Prophylaxis (PrEP) for HIV prevention in Namibia. Namibia became the first country to include and introduce PrEP in its National HIV epidemic control strategy in Africa.

Dr. Borse was a Senior Technical Advisor at USAID’s Office of HIV/AIDS. He led PEPFAR-supported new product research and development and implementation science portfolio such as new product introduction (HIV-PrEP) activities for adolescent girls and young women, Implementation science, and served as a USAID reviewer for the PEPFAR-Kenya annual COP meetings. Before that, Dr. Borse led international vaccine work at Merck’s Global Health Outcomes. He managed projects and research studies for the HPV vaccine introduction in Latin America and Eastern Europe.

In 2008, Dr. Borse started as an Epidemic Intelligence Service (EIS) officer with CDC and led the 2009 Pandemic Influenza-A (H1N1) response, and served as the WHO Stop Transmission of Polio (STOP) member in the Philippines. After EIS, he continued as a senior health scientist at CDC’s Global AIDS Program (GAP) and led Uganda’s PEPFAR-funded Health Systems Public Health Evaluation (PHE).

Dr. Borse has a Ph.D. in International Health/Health Systems from Johns Hopkins University and has completed a M.A. in International Relations from Syracuse University’s Maxwell School and an M.S. in Epidemiology from Michigan State University’s College of Human Medicine. Dr. Borse has earned certificates in Disaster Management & Humanitarian Assistance from ICRC and International Health Policy and Financing from Johns Hopkins University.

Dr. Borse has published over 25 manuscripts and book chapters, presented at over 40 global conferences, and serves as a peer reviewer for journals on international health topics.

Dr. Borse is originally from Mumbai, India, and migrated to the US as a student in 2002. He lives in Washington, D.C. with his wife and two kids. Along with cooking, traveling, painting, gardening, and watching cricket, Dr. Borse enjoys spending his weekends playing with his kids.